patent-law

136 cases — ← All topics

Case Title Lower Court Docketed Status Flags Tags Question Presented
25-953 Finesse Wireless LLC v. AT&T Mobility LLC, et al. Federal Circuit 2026-02-11 Pending credibility-determination expert-testimony federal-circuit judgment-as-matter-of-law jury-verdict patent-law Whether a purported inconsistency in the testimony of an expert witness is an issue of credibility for the jury to resolve, as every regional circuit …
25-555 SurfCast, Inc. v. Microsoft Corporation Federal Circuit 2025-11-06 Denied Response Waived administrative-law due-process federal-circuit judicial-procedure patent-law property-rights Whether 35 U.S.C. § 144, which requires the Federal Circuit to issue "opinion[s]" in PTAB appeals, is a reasoning-giving directive that prohibits the …
25-5989 Chian Chiu Li v. Apple, Inc. Federal Circuit 2025-10-29 Denied Response WaivedIFP enablement negative-limitation patent-law specification-requirement statutory-interpretation written-description Section 112(a) of Title 35 requires that a patent include a specification containing "a written description of the invention ... in such full, clear, …
25-375 CPC Patent Technologies Pty Ltd. v. Apple Inc. Federal Circuit 2025-09-30 Denied Response Waived administrative-review appellate-procedure federal-circuit patent-law rule-36 statutory-interpretation Whether Federal Circuit Rule 36, which allows the United States Court of Appeals for the Federal Circuit to issue an affirmance without opinion when r…
25A179 EcoFactor, Inc. v. Google, LLC Federal Circuit 2025-08-12 Presumed Complete due-process expert-testimony federal-circuit harmless-error patent-law seventh-amendment Whether the Federal Circuit improperly supplanted the jury's fact-finding role and violated due process by granting a new trial on damages in a patent…
24-1311 Kevin T. Lavery v. Pursuant Health, Inc. Sixth Circuit 2025-06-25 Denied Response Waived circuit-split contract-interpretation patent-law patent-misuse royalty-agreement stare-decisis Whether the Court should overrule Brulotte and Kimble or at least clarify that an agreement containing a post-expiration royalty is not per se patent …
24A1215 MSN Pharmaceuticals, Inc., et al v. Novartis Pharmaceuticals Corporation Federal Circuit 2025-06-10 Presumed Complete after-arising-technology enablement-doctrine federal-circuit genus-claim patent-law patent-validity Whether a patent may validly claim a genus without describing or enabling species of the genus that utilize after-arising technology
24-1137 NexStep, Inc. v. Comcast Cable Communications, LLC Federal Circuit 2025-05-06 Denied Response Waived doctrine-of-equivalents expert-testimony federal-circuit jury-verdict patent-infringement patent-law Whether a patentee must in every case present 'particularized testimony and linking argument' to establish infringement under the doctrine of equivale…
24-1132 Purdue Pharma L.P., et al. v. Accord Healthcare, Inc. Federal Circuit 2025-05-02 Denied federal-circuit non-obviousness obviousness patent-law pharmaceutical-innovation secondary-considerations Whether the objective indicia of non-obviousness should be analyzed flexibly to combat hindsight bias or subject to the Federal Circuit's rigid rules …
24-950 Urvashi Bhagat v. United States Patent and Trademark Office, et al. Federal Circuit 2025-03-05 Denied Response Waived constitutional-standards due-process expert-testimony innovation nutrition-arts patent-law Whether lower courts erred in prejudicing innovation in nutrition arts by failing to uphold constitutional standards for patent advancement and due pr…
24-6473 Joshua Gunnar Olson v. United States Eighth Circuit 2025-02-05 Denied Response WaivedIFP administrative-law claim-construction federal-circuit judicial-review patent-law patent-procedure Whether the Federal Circuit correctly interpreted the scope of patent-related claims and standards of review for administrative patent determinations
24-827 Broadband iTV, Inc. v. Amazon.com, Inc., et al. Federal Circuit 2025-02-04 Denied alice-test claim-construction material-fact patent-eligibility patent-law summary-judgment Whether there is a patent-specific exception to Rule 56, such that courts may grant summary judgment of patent ineligibility despite genuine disputes …
24-726 DISH Network L.L.C. v. Dragon Intellectual Property LLC, et al. Federal Circuit 2025-01-10 Denied Amici (3)Response Waived administrative-proceeding attorney-fees district-court-discretion fee-shifting joint-and-several-liability patent-law Whether the Patent Act's fee-shifting statute allows a district court discretion to impose joint and several liability for attorney fees and to award …
24A661 Nazir Khan v. Merit Medical Systems, Inc. Federal Circuit 2025-01-03 Presumed Complete appellate-review district-court en-banc-petition legal-reasoning patent-law summary-judgment Whether a district court's summary judgment ruling in a patent-related case can be affirmed without a comprehensive written opinion explaining the leg…
24-635 Celanese International Corporation, et al. v. International Trade Commission, et al. Federal Circuit 2024-12-11 Denied Amici (2) america-invents-act on-sale-bar patent-invalidation patent-law process-claims secret-process Whether the sale of an end product made by a secret process invalidates the patent on that process under the America Invents Act when the process itse…
24-518 ParkerVision, Inc. v. TCL Industries Holdings Co., Ltd., et al. Federal Circuit 2024-11-06 Denied Amici (11)Response RequestedResponse WaivedRelisted (2) administrative-law appellate-review due-process judicial-procedure patent-law property-rights Whether 35 U.S.C. § 144, which requires the Federal Circuit to issue 'opinion[s]' in PTAB appeals, is a reason-giving directive that prohibits the Fed…
24-461 Island Intellectual Property LLC v. TD Ameritrade, Inc., et al. Federal Circuit 2024-10-23 Denied Amici (3)Relisted (2) appellate-procedure due-process local-rule-36 patent-law seventh-amendment summary-judgment Whether the Federal Circuit's use of Local Rule 36 to issue one-word affirmances in patent cases violates due process and the right to reasoned appell…
24-294 Norwich Pharmaceuticals Inc. v. Salix Pharmaceuticals, Ltd., et al. Federal Circuit 2024-09-13 Denied fda-approval generic-drugs hatch-waxman-act injunctive-relief patent-law statutory-interpretation Whether 35 U.S.C. § 271(e)(4)(A) requires courts to issue overly broad injunctive orders that delay FDA approval of generic drug applications beyond t…
24-47 Return Mail, Inc. v. United States Federal Circuit 2024-07-16 Denied 35-usc-101 abstract-idea alice-corporation-v-cls-bank innovation judicial-interpretation patent patent-eligibility patent-law return-mail-inc-v-united-states-postal-service section-101 Whether the claimed invention is ineligible for patent protection under the abstract-idea exception to 35 U.S.C. §101
23-1349 Provisur Technologies, Inc. v. Weber, Inc. Federal Circuit 2024-06-27 Denied Response Waived confidentiality federal-circuit inter-partes-review on-sale-bar patent-law patent-law-35-usc-311-b printed-publication prior-art public-accessibility Did the Federal Circuit err in holding that a product manual distributed with an on-sale product constitutes a printed publication that can be asserte…
23A1111 Roku, Inc. v. International Trade Commission, et al. Federal Circuit 2024-06-14 Presumed Complete certiorari-extension federal-circuit patent-law statutory-interpretation technology-dispute trade-commission Whether the Federal Circuit correctly interpreted the statutory framework governing patent-related trade disputes between technology companies and the…
23A988 Return Mail, Inc. v. United States Federal Circuit 2024-05-06 Presumed Complete 35-usc-101 abstract-idea federal-circuit patent-eligibility patent-law supreme-court-review Whether the Federal Circuit incorrectly applied the abstract-idea exception to patent eligibility under 35 U.S.C. §101 in a manner that undermines pat…
23-6984 Chikezie Ottah v. Verifone System Inc. Federal Circuit 2024-03-15 Denied Response WaivedIFP 35-usc-101 civil-procedure constitutional-provisions court-jurisdiction judicial-review legal-interpretation patent-eligibility patent-law procedural-rules standing statutory-provisions takings Whether the question of law presented in the petition for writ of certiorari should be reviewed
23A685 Evan H. Nordby v. Social Security Administration Federal Circuit 2024-01-24 Presumed Complete federal-circuit judicial-review notice-of-appeal patent-law supreme-court-rule time-extension Whether a patent applicant may seek judicial review of a Patent Trial and Appeal Board decision after failing to timely file a notice of appeal
23-768 Vanda Pharmaceuticals Inc. v. Teva Pharmaceuticals USA, Inc., et al. Federal Circuit 2024-01-17 Denied Amici (3)Response RequestedResponse WaivedRelisted (2) federal-circuit innovation-standard ksr-international-co-v-teleflex KSR-precedent obviousness obviousness-standard patent patent-law predictable-results reasonable-expectation-of-success Whether obviousness requires a showing of 'predictable' results, as this Court held in KSR, or a mere 'reasonable expectation of success,' as the Fede…
23-739 Jodi A. Schwendimann, fka Jodi A. Dalvey v. Neenah, Inc., et al. Federal Circuit 2024-01-09 Denied 35-usc-103 federal-circuit-review ksr-standard ksr-v-teleflex obviousness patent-law primary-reference prior-art wbip-v-kohler yeda-v-mylan Obviousness analysis under 35 U.S.C. § 103
23-575 Fleur Tehrani v. Hamilton Technologies LLC Federal Circuit 2023-11-28 Denied 35-usc-103 federal-circuit obviousness patent patent-invalidation patent-law posita prior-art Whether the Court of Appeals for the Federal Circuit erred in its analysis
23-494 MacNeil IP LLC v. Yita LLC Federal Circuit 2023-11-09 Denied Response WaivedRelisted (2) administrative-law agency-deference appellate-procedure fact-finding judicial-review patent patent-law remand standard-of-review Whether the Federal Circuit erred in substituting its own findings of fact for those of the Patent Trial and Appeal Board instead of remanding as requ…
23-421 Alfonso Cioffi, et al. v. Google LLC Federal Circuit 2023-10-20 Denied Response Waived 35-usc-251 embodiment-standard federal-circuit original-patent patent patent-disclosure patent-law patent-reissue reissue statutory-interpretation u.s.-industrial-chemicals Should the Antares Pharma, Inc. v. Medac Pharma Inc., 771 F.3d 1354, 1358 (Fed. Cir. 2014) 'exact embodiment' standard for 'original patent' disclosur…
23A344 Vanda Pharmaceuticals Inc. v. Teva Pharmaceuticals USA, Inc., et al. Federal Circuit 2023-10-17 Presumed Complete KSR-standard obviousness patent-law pharmaceutical-patents predictable-result prior-art Whether the Federal Circuit's obviousness analysis complies with the Supreme Court's standard in KSR International Co. v. Teleflex Inc. by requiring t…
23-347 Rowland J. Martin, Jr. v. Edward Bravenec, et al. Federal Circuit 2023-10-03 Denied civil-rights judicial-review micro-entity micro-entity-inventor patent-franchise patent-law patent-office purchase-money-lien quiet-title quiet-title-relief removal-proceeding slapp-suit Whether statutory provisions for removal of a state court case to federal court authorize judicial review, where the removal proceeding is an alleged …
22-927 Nike, Inc. v. Adidas AG, et al. Federal Circuit 2023-03-23 Denied Response RequestedResponse WaivedRelisted (2) 35-usc-316 america-invents-act claim-construction inter-partes-review patent-holder patent-law patent-trial-and-appeal-board prior-art substitute-claims Whether, in inter partes review, the Patent Trial and Appeal Board may raise sua sponte a new ground of prior art that the petitioner neither cited no…
22-919 Stephen Thaler v. Katherine K. Vidal, Under Secretary of Commerce for Intellectual Property and Director, United States Patent and Trademark Office, et al. Federal Circuit 2023-03-21 Denied Amici (3)Response Waived artificial-intelligence innovation-rights invention inventor inventor-definition patent patent-act patent-eligibility patent-law standing statutory-interpretation Does the Patent Act categorically restrict the statutory term 'inventor' to human beings alone?
22-873 Ingenio, Inc., et al. v. Click-to-Call Technologies LP Federal Circuit 2023-03-13 Denied Response RequestedResponse WaivedRelisted (2) america-invents-act estoppel federal-circuit inter-partes-review patent-law statutory-interpretation Whether 35 U.S.C. § 315(e)'s IPR estoppel provision applies only to claims addressed in the final written decision, even if other claims were or could…
22-794 Eurica Califorrniaa v. Katherine K. Vidal, Under Secretary of Commerce for Intellectual Property and Director, United States Patent and Trademark Office Federal Circuit 2023-02-22 Denied Response WaivedRelisted (2) abortion civil-rights dobbs-v-jackson due-process patent-law patent-term roe-v-wade specification-claims unborn-rights vuitch vuitch-precedent Whether United States v. Vuitch, 402 U.S. 62 (1971), should be overruled in favor of equality with the unborn?
22-671 Novartis Pharmaceuticals Corporation v. HEC Pharm Co., Ltd., et al. Federal Circuit 2023-01-20 Denied Amici (3) 28-usc-46 appellate-procedure case-law judicial-administration judicial-review panel-composition patent-law statutory-interpretation written-description Whether 28 U.S.C. §46 and principles of sound judicial administration preclude a court of appeals from adding a new judge to form a new panel and rede…
22-604 Garth Janke v. Kathi Vidal, Under Secretary of Commerce for Intellectual Property and Director, United States Patent and Trademark Office Federal Circuit 2022-12-30 Denied Response Waived 3d-printing gottschalk-v-benson mathematical-model parker-v-flook patent-eligibility patent-law patent-monopoly product-preemption Can a known patentable product become ineligible for patenting when it is claimed to be made by applying a mathematical model of the product on a 3D p…
22-5928 David L. Hildebrand v. Wilmar Corporation Tenth Circuit 2022-10-28 Denied Response WaivedIFP antitrust business-dealings contract-law contractual-law due-process patent-expiration patent-law royalties royalty-agreement settlement-intent standing Is it illegal to agree to continue to pay royalties or fees of any kind to an inventor following the expiration of his patent?
22-298 Jump Rope Systems, LLC v. Coulter Ventures, LLC, dba Rogue Fitness Federal Circuit 2022-09-28 Denied Amici (5)Response RequestedResponse WaivedRelisted (2) collateral-estoppel federal-circuit inter-partes-review patent-infringement patent-law patent-validity preclusion-doctrine restatement-of-judgments Whether a PTAB determination of unpatentability has collateral estoppel effect on patent validity in district court
22-203 Apple Inc., et al. v. California Institute of Technology Federal Circuit 2022-09-07 Denied CVSGAmici (3)Response RequestedResponse WaivedRelisted (3) administrative-procedure administrative-process civil-procedure federal-circuit inter-partes-review patent patent-law patent-validity standing statutory-interpretation Whether the Federal Circuit erroneously extended IPR-estoppel under 35-USC-315(e)(2) to all grounds that reasonably-could-have-been-raised in the peti…
22-38 CPC Patent Technologies PTY Ltd. v. Apple Inc. Federal Circuit 2022-07-13 Denied 28-usc-1404a federal-circuit jurisdictional-limits mandamus patent-law statutory-interpretation subject-matter-jurisdiction venue-transfer writ-of-mandamus Whether the Federal Circuit has subject matter jurisdiction over a petition for writ of mandamus challenging a denial of a motion to transfer venue un…
22-11 SawStop Holding LLC v. United States Patent and Trademark Office, et al. Federal Circuit 2022-07-05 Denied Response Waived 35-usc-101 35-usc-102 35-usc-103 judicial-authority non-statutory-double-patenting patent patent-eligibility patent-law statutory-interpretation ultra-vires Does the judiciary have the authority to require a patent applicant to meet a condition for patentability not required by the Patent Act?
21-1566 Juno Therapeutics, Inc., et al. v. Kite Pharma, Inc. Federal Circuit 2022-06-15 Denied Amici (5)Relisted (6) 35-usc-112(a) enablement federal-circuit invention-scope inventor-possession patent patent-law patent-specification statutory-interpretation written-description Whether the written description requirement under 35 USC 112(a) should be measured by the statutory standard or the Federal Circuit's 'possession' tes…
21-1567 Biogen International GmbH, et al. v. Mylan Pharmaceuticals Inc. Federal Circuit 2022-06-15 Denied Amici (2) 35-usc-112 effective-dose efficacy-requirement federal-circuit multiple-sclerosis patent patent-law patent-specification statutory-interpretation written-description Is 35 U.S.C. § 112's written-description requirement met when the specification describes the invention?
21-1527 CustomPlay, LLC v. Amazon.com, Inc., et al. Federal Circuit 2022-06-06 Denied Response Waived administrative-procedure america-invents-act due-process inter-partes-review patent patent-law patent-rights patent-trial-and-appeal-board statutory-interpretation trademark Whether the PTO violated the AIA by delegating the Director's responsibility to the PTAB
21-1093 PersonalWeb Technologies LLC v. Google LLC, et al. Federal Circuit 2022-02-07 Denied Response Waived abstract-idea alice-corp-v-cls-bank computer-implemented-invention computer-implemented-inventions federal-circuit innovation patent-eligibility patent-law technical-field How should courts determine whether a patent for a computer-implemented invention is patent-eligible because it 'improve[s] the functioning of the com…
21-1036 Gamon Plus, Inc. v. Campbell Soup Company, et al. Federal Circuit 2022-01-24 Denied Response Waived administrative-law appointments-clause arthrex-precedent federal-circuit judicial-remand patent-law patent-review rehearing-petition remand separation-of-powers Whether the Court should vacate the judgment below and remand for further proceedings in light of Arthrex
21-893 Apotex Inc., et al. v. Cephalon, Inc., et al. Federal Circuit 2021-12-16 Denied 35-usc-103 drug-reformulation inventive-process ksr-v-teleflex motivation motivation-to-combine obviousness obviousness-standard patent patent-law person-of-ordinary-skill prior-art Whether claimed inventions involving reformulating and administering an old drug in ways that are no better than prior techniques, and which had been …
21-757 Amgen Inc., et al. v. Sanofi, et al. Federal Circuit 2021-11-22 Judgment Issued CVSGAmici (33)Response RequestedRelisted (4) 35-usc-112 claim-construction claim-scope enablement enablement-requirement invention-disclosure judicial-review patent patent-law statutory-interpretation undue-experimentation written-description Whether enablement is a question of fact or law
21-438 Olaf Sööt Design, LLC v. Daktronics, Inc., et al. Federal Circuit 2021-09-22 Denied CVSGAmici (1)Response RequestedResponse WaivedRelisted (3) appellate-review claim-construction infringement jury-trial jury-verdict patent patent-law seventh-amendment sua-sponte Whether the Seventh Amendment allows the Federal Circuit to reverse a jury verdict based on a sua sponte new claim construction
21-413 Infinity Computer Products, Inc. v. Oki Data Americas, Inc. Federal Circuit 2021-09-15 Denied Response RequestedResponse WaivedRelisted (2) 35-usc-112 claim-construction claim-interpretation definiteness-standard expert-testimony indefiniteness patent patent-law patent-specification person-skilled-in-the-art prosecution-history Whether a patent claim is indefinite under § 112, ¶ 2, if conflicting positions about a claim term arise during the patent prosecution process, even i…
21-170 Rain Computing, Inc. v. Samsung Electronics America, Inc., et al. Federal Circuit 2021-08-05 Denied 35-usc-112 35-usc-112f claim-construction federal-circuit indefiniteness nautilus-standard nautilus-v-biosig patent patent-law statutory-interpretation Whether a patent claim may be invalidated for indefiniteness
20-1809 VoIP-Pal.com, Inc. v. Apple, Inc., et al. Federal Circuit 2021-06-29 Denied 35-usc-101 innovation innovation-incentives judicial-framework legal-uncertainty patent-act patent-eligibility patent-law patent-system statutory-interpretation subject-matter-eligibility What is the appropriate standard for determining patent-eligibility under 35 U.S.C. §101?
20-1604 Biogen MA Inc. v. EMD Serono, Inc., et al. Federal Circuit 2021-05-18 Denied anticipation claim-construction incentives medical-treatment method-of-treatment novelty patent patent-law patent-validity prior-art recombinant-protein Whether courts may disregard the express claim term 'recombinant' so as to render a method-of-treatment patent anticipated—and thus invalid—in light o…
20-1420 Roadie, Inc. v. Baggage Airline Guest Services, Inc. Federal Circuit 2021-04-09 Denied attorney-fees claim-construction exceptional-case highmark-v-allcare infringement infringement-claim judicial-discretion octane-fitness-v-icon patent-law patent-statute-35-usc-285 Whether district courts should consider the weakness of an infringement claim after ruling in favor of the defendant on invalidity
20-1394 PersonalWeb Technologies, LLC v. Patreon, Inc., et al. Federal Circuit 2021-04-06 Denied CVSGAmici (2)Response RequestedResponse WaivedRelisted (3) civil-procedure claim-preclusion federal-circuit issue-preclusion judicial-interpretation kessler-doctrine patent-law preclusion-doctrine voluntary-dismissal Whether the Federal Circuit correctly interpreted Kessler to create a freestanding preclusion doctrine
20-1380 Security People, Inc. v. Drew Hirshfeld, Acting Under Secretary of Commerce for Intellectual Property and Director, United States Patent and Trademark Office, et al. Federal Circuit 2021-04-01 Denied Response Waived constitutional-challenge due-process federal-circuit fifth-amendment inter-partes-review jurisdiction patent patent-law retroactive-application vested-property Whether the retroactive application of inter partes review deprived Petitioner of its vested property in violation of the Due Process Clause
20-7519 Angadbir Singh Salwan v. Drew Hirshfeld, Acting Under Secretary of Commerce for Intellectual Property and Director of the United States Patent and Trademark Office Federal Circuit 2021-03-22 Denied Response WaivedIFP abstract-idea administrative-law civil-rights due-process intellectual-property judicial-corruption patent patent-law standing supreme-court-precedent takings Whether the lower courts' rulings are tainted by corruption financed by China's Communist party, and whether the Supreme Court should reverse the CAFC…
20-1284 Warsaw Orthopedic, Inc., et al. v. Rick C. Sasso Federal Circuit 2021-03-17 Denied Response RequestedResponse WaivedRelisted (2) abstention claim-construction exclusive-jurisdiction federal-abstention federal-jurisdiction patent-infringement patent-jurisdiction patent-law state-court-proceedings Whether a federal court with exclusive jurisdiction over a federal patent-law dispute may abstain in favor of a state court with no jurisdiction over …
20-1291 WPEM, LLC v. SOTI Inc. Federal Circuit 2021-03-17 Denied 35-usc-282 35-usc-285 clear-and-convincing-evidence district-court-discretion exceptional-case patent-law patent-validity prior-art Does a patent's presumption of validity afforded by 35 U.S.C. §282 limit a district court's discretion to find a case exceptional under 35 U.S.C. §285…
20-1258 Ono Pharmaceutical Co., Ltd., et al. v. Dana-Farber Cancer Institute, Inc. Federal Circuit 2021-03-11 Denied conception conception-standard federal-circuit-rule inventorship-correction joint-inventorship non-obviousness novelty patent-law prior-art Whether the Federal Circuit erred in adopting a bright-line rule that the novelty and non-obviousness of an invention over alleged contributions that …
20-1165 Lakshmi Arunachalam v. Citigroup, Inc., et al. Federal Circuit 2021-02-24 Denied 35-usc-282 access-to-courts collateral-estoppel constitutional-rights due-process patent-law separation-of-powers supreme-court-precedent Whether the inferior courts arbitrarily claiming collateral estoppel without once proving it nor applying Supreme Court precedent dating back more tha…
20-1119 Amarin Pharma, Inc., et al. v. Hikma Pharmaceuticals USA Inc., et al. Federal Circuit 2021-02-16 Denied Amici (3)Response RequestedResponse WaivedRelisted (2) 35-usc-103 graham-factors graham-v-john-deere hindsight-bias innovation innovation-protection nonobviousness-indicia objective-indicia obviousness-standard patent patent-law Whether a court must consider objective indicia of nonobviousness together with the other factors bearing on an obviousness challenge before making an…
20-1112 In Re Lakshmi Arunachalam 2021-02-12 Denied Response Waived administrative-law appointments-clause constitutional-law contract-clause due-process equal-protection government-contracts patent patent-law separation-of-powers stare-decisis Whether Justice Barrett must enforce the Supreme Court's stare decisis precedents prohibiting repudiation of government-issued patent grants
20-891 American Axle & Manufacturing, Inc. v. Neapco Holdings LLC, et al. Federal Circuit 2021-01-05 Denied CVSGAmici (11)Response RequestedResponse WaivedRelisted (4) 35-usc-101 alice-v-cls claim-construction judicial-exception judicial-exceptions patent-eligibility patent-ineligibility patent-law standard-of-review two-step-framework What is the appropriate standard for determining patent eligibility under 35 U.S.C. § 101?
20-863 Akeva L.L.C. v. Nike, Inc., et al. Federal Circuit 2020-12-30 Denied Amici (1)Response WaivedRelisted (2) 35-usc-112 claim-construction claim-interpretation federal-circuit-split innovation-goals judicial-precedent patent-claim-construction patent-law patent-property-rights predictability property-rights public-notice Whether the Federal Circuit's 'heavy presumption' line of cases or its 'holistic' line should govern claim construction
20-769 GS Cleantech Corporation, et al. v. Adkins Energy LLC, et al. Federal Circuit 2020-12-04 Denied Amici (1)Response Waived appellate-review civil-procedure de-novo-review federal-circuit patent patent-act patent-law standard-of-review summary-judgment Whether the Federal Circuit, in cases arising under the Patent Act, may depart from the uniform rule of the other Circuit Courts that an issue resolve…
20-751 Ashley Ann Krapacs v. The Florida Bar Florida 2020-12-01 Denied Response WaivedRelisted (2) abstract-idea administrative-law bar-discipline civil-rights disbarment due-process first-amendment fourteenth-amendment free-speech free-speech 20-7519" integrated-bar intellectual-property judicial-corruption patent-law political-speech professional-conduct state-action supreme-court-precedent Whether the Supreme Court will address alleged jud Whether the state action of disbarment violates the First Amendment as applied to the States through the Fourteenth Amendment
20-440 Minerva Surgical, Inc. v. Hologic, Inc., et al. Federal Circuit 2020-10-06 Judgment Issued Amici (12)Relisted (2) 35-usc-282 assignor-estoppel due-process judicial-doctrine patent patent-infringement patent-invalidity patent-law statutory-interpretation Whether a defendant in a patent infringement action who assigned the patent, or is in privity with an assignor of the patent, may have a defense of in…
20-424 IYM Technologies LLC v. RPX Corporation, et al. Federal Circuit 2020-10-02 Denied Response Waived appointments-clause arthrex constitutional-claim federal-circuit forfeiture inter-partes-review patent patent-law standing Whether a court of appeals can invoke forfeiture to refuse to address a constitutional claim in a pending appeal despite an intervening change in law
20-408 Fredman Bros. Furniture Company, Inc. v. Bedgear, LLC Federal Circuit 2020-09-29 Dismissed Relisted (2) administrative-officers administrative-patent-judges appointments-clause constitutional-law inferior-officers judicial-review patent-law principal-officers separation-of-powers united-states Whether administrative patent judges are 'principal' or 'inferior' Officers of the United States within the meaning of the Appointments Clause
20-380 Idenix Pharmaceuticals LLC, et al. v. Gilead Sciences, Inc. Federal Circuit 2020-09-24 Denied Amici (3)Response RequestedResponse WaivedRelisted (2) 35-usc-112a enablement genus-claim genus-claims patent patent-law pharmaceutical-innovation pharmaceuticals statutory-interpretation written-description Whether the Federal Circuit's genus-claim-specific enablement rule and separate 'possession' requirement are consistent with 35 U.S.C. § 112(a)
20-364 Thomas Wilkins v. United States District Court for the Eastern District of California Federal Circuit 2020-09-18 Denied Relisted (2) administrative-procedure article-iii-jurisdiction civil-rights due-process federal-circuit inventor-correction inventorship jurisdiction patent patent-law standing uspto-procedure Whether the USITC, district court, and Federal Circuit lacked Article III jurisdiction over the patent inventorship dispute
20-313 Acer America Corporation, et al. v. Intellisoft, Ltd., et al. Federal Circuit 2020-09-10 Denied Response Waived 28-usc-1451 claim-construction federal-jurisdiction gunn-v-minton inventorship patent-law removal removal-jurisdiction trade-secret Where Plaintiffs' theories of trade secret ownership, misappropriation, and damages depend on deciding the patent law issues of inventorship, claim co…
20-260 Personal Audio, LLC v. CBS Corporation Federal Circuit 2020-09-01 Denied appointments-clause collateral-estoppel inter-partes-review patent-law reexamination-clause seventh-amendment waiver Must the collateral estoppel effect of an inter partes review be raised and litigated in the appeal of the inter partes review, rather than in the cou…
20-230 Donald L. Baker v. Andrei Iancu, Director, United States Patent and Trademark Office, et al. Tenth Circuit 2020-08-27 Denied Response Waived administrative-law agency-misconduct civil-rights due-process judicial-notice judicial-review patent patent-law pro-se-litigation retaliation Whether U.S. Agencies may commit fraudulent acts to obstruct and delay applications
20-158 SRAM, LLC v. FOX Factory, Inc. Federal Circuit 2020-08-13 Denied Response Waived 35-usc-103 commercial-success federal-circuit graham-v-john-deere nonobviousness objective-indicia patent-act patent-claim patent-law person-of-ordinary-skill secondary-considerations statutory-interpretation Whether the Federal Circuit erred in holding that, under 35 U.S.C. § 103, before a nexus can be presumed between objective indicia of nonobviousness a…
20-68 Cheetah Omni LLC v. AT&T Services, Inc., et al. Federal Circuit 2020-07-24 Denied Response Waived contract-interpretation contract-law federal-circuit federal-common-law implied-license license-continuation patent patent-law rodriguez-v-fdic uniquely-federal-interests Did the Federal Circuit violate Rodriguez when it invoked its own federal common law rule, superseding controlling state contract law, to hold that a …
19-1475 Duke University v. Biomarin Pharmaceutical Inc. Federal Circuit 2020-07-08 Denied 35-usc-314 administrative-law administrative-patent-judges appointments-clause due-process forfeiture inter-partes-review patent patent-law standing statutory-interpretation Whether a court of appeals can invoke forfeiture to refuse to address an Appointments Clause violation in a pending appeal despite an intervening chan…
19-1459 Polaris Innovations Limited v. Kingston Technology Company, Inc., et al. Federal Circuit 2020-07-06 GVR Amici (2)Relisted (3) 35-usc-311 administrative-patent-judges appointments-clause civil-service-protections congressional-intent constitutional-remedy ipr-statute patent-law severance statutory-interpretation tenure-protections Whether severance of the tenure protections for Administrative Patent Judges ('APJs) was unavailable to the Arthrex court to remedy the violation of t…
19-1451 Sanofi-Aventis Deutschland GmbH v. Mylan Pharmaceuticals Inc. Federal Circuit 2020-07-02 Denied administrative-law appointments-clause constitutional-challenge federal-circuit forfeiture ksr-international-co-v-teleflex-inc obviousness patent-act patent-law patent-trial-and-appeal-board pending-case separation-of-powers Whether a court can refuse to entertain a constitutional, separation-of-powers challenge based on an intervening change of law on the grounds of forfe…
19-1204 Arthrex, Inc. v. Smith & Nephew, Inc., et al. Federal Circuit 2020-04-09 Denied administrative-law appointments-clause constitutional-challenge due-process fifth-amendment inter-partes-review patent-law patent-law-retroactivity patent-office retroactive-application retroactivity takings Whether the retroactive application of inter partes review to patents that were applied for before the America Invents Act violates the Fifth Amendmen…
19-1131 Actavis Laboratories FL, Inc. v. Nalpropion Pharmaceuticals LLC Federal Circuit 2020-03-16 Denied Amici (1) 35-usc-112 claim-construction federal-circuit patent-claims patent-law patent-law-35-usc-112 patent-specification patent-validity statutory-interpretation written-description written-description-requirement Whether § 112 requires a patent's specification to contain a written description of all of the limitations of a patent's claims, not just a 'substanti…
19-1132 Blackbird Tech LLC, dba Blackbird Technologies v. Health in Motion LLC, dba Inspire Fitness, et al. Federal Circuit 2020-03-16 Denied Response Waived attorney-fees case-by-case-analysis exceptional-case judicial-determination litigating-position litigation-discretion octane-fitness patent-act patent-law patent-litigation Can a court consider factors unrelated to the instant case in determining whether a particular case is exceptional?
19-7905 Lakshmi Arunachalam v. Exxon Mobil Corporation Fifth Circuit 2020-03-09 Dismissed Relisted (2)IFP civil-rights constitutional-emergency constitutional-interpretation contract-clause due-process government-grants judicial-misconduct judicial-precedent martial-law patent patent-law patent-rights separation-of-powers treason Whether the concerted wanton breach of solemn Oaths collectively failing to enforce the Laws of the Land and Stare Decisis Laws of the Case constitute…
19-1073 Enzo Life Sciences, Inc. v. Roche Molecular Systems, Inc., et al. Federal Circuit 2020-03-02 Denied Response Waived 35-usc-112 35-usc-282 clear-and-convincing-standard enablement inoperability non-enabled-claims patent-law patent-validity presumption-of-validity statutory-interpretation unpredictability Whether patent claims that cover a class may be invalidated as non-enabled under 35 U.S.C. § 112 based on a finding of high unpredictability in the ar…
19-7798 Pablo Cantu Hernandez v. United States Fifth Circuit 2020-02-27 Denied Response WaivedIFP administrative-law administrative-procedure civil-procedure civil-rights due-process extraordinary-circumstances mootness patent-law standing takings Whether petitioner's claims became moot under extraordinary and unusual circumstances that were beyond the petitioner's control under the CARES Act of…
19-1061 Dr. Reddy's Laboratories, Ltd., et al. v. Eli Lilly and Company Federal Circuit 2020-02-26 Denied Amici (2) claim-amendment doctrine-of-equivalents festo-corp-v-shoketsu festo-corp-v-shoketsu-kinzoku-kogyo-kabushiki-co patent-claim patent-infringement patent-law patent-law-doctrine-of-equivalents patent-prosecution prosecution-history-estoppel tangential-exception Whether patent owners may recapture subject matter they could have claimed in prosecution but did not, by arguing that they surrendered more than they…
19-1062 CJ CheilJedang Corp., et al. v. International Trade Commission, et al. Federal Circuit 2020-02-26 Denied Amici (1) claim-amendment doctrine-of-equivalents festo-corp-v-shoketsu innovation patent-infringement patent-law prosecution-history-estoppel public-notice public-notice-function tangential-relation Whether, to avoid prosecution history estoppel under Festo Corp. v. Shoketsu Kinzoku Kogyo Kabushiki Co., 'the rationale underlying the amendment' mus…
19-1012 General Electric Company v. Raytheon Technologies Corporation, fka United Technologies Corporation Federal Circuit 2020-02-14 Denied Amici (2) article-iii article-iii-standing civil-procedure civil-rights competition competitive-harm competitor-standing due-process inter-partes-review judicial-precedent patent patent-infringement patent-law standing Whether competitive harm alone suffices to confer Article III standing to appeal an IPR determination, or whether an appellant must also show concrete…
19-1002 Automotive Body Parts Association v. Ford Global Technologies, LLC Federal Circuit 2020-02-11 Denied Response Waived article-of-manufacture design-patent design-patents federal-circuit patent-exhaustion patent-law patent-rights repair-doctrine right-to-repair samsung-v-apple How should the article of manufacture be determined when applying the patent exhaustion and repair doctrines in design patent cases?
19-829 Chrimar Systems, Inc. v. Juniper Networks, Inc., et al. Federal Circuit 2019-12-31 Denied Response Waived administrative-procedure burden-of-proof due-process evidence inter-partes-review patent patent-challenge patent-law reply reply-evidence Did the Patent and Trademark Trial and Appeal Board violate 35-USC-312(a)(3) and 35-USC-316(a)(8)
19-619 Cisco Systems, Inc. v. SRI International, Inc. Federal Circuit 2019-11-14 Denied 35-usc-101 abstract-idea computer-automated-method computer-automation computer-network data-analysis data-collection patent patent-eligibility patent-law standing statutory-interpretation Whether patent claims that recite only the abstract idea of collecting and analyzing data are patent-ineligible under 35 U.S.C. § 101 and Alice
19-597 Morris Reese v. Sprint Nextel Corporation, et al. Federal Circuit 2019-11-07 Denied Response RequestedResponse WaivedRelisted (2) 35-usc-101 abstract-idea alice-framework alice-v-cls-bank federal-circuit mayo-v-prometheus patent-eligibility patent-ineligible-concept patent-law section-101 Whether the claims at issue are directed to an abstract idea under 35 U.S.C. § 101
19-584 Nuvo Pharmaceuticals (Ireland) Designated Activity Company, et al. v. Dr. Reddy's Laboratories Inc., et al. Federal Circuit 2019-11-04 Denied Response Waived 35-usc-112 enablement federal-circuit innovation patent patent-law pharmaceutical pharmaceutical-composition prior-art written-description Whether the Federal Circuit erred by holding that, whenever the prior art teaches away from a pharmaceutical composition, the written description of a…
19-521 ChargePoint, Inc. v. SemaConnect, Inc. Federal Circuit 2019-10-22 Denied Amici (2) 35-usc-101 abstract-idea alice-corp-v-cls-bank alice-v-cls-bank diamond-v-diehr innovation judicial-interpretation machine-or-process patent-eligibility patent-law section-101 Whether a patent claim to a new and useful improvement to a machine or process may be patent eligible even when it 'involves' or incorporates an abstr…
19-455 ARRIS International Limited v. ChanBond, LLC, et al. Federal Circuit 2019-10-07 Denied Response WaivedRelisted (3) 35-usc-315 35-usc-315(b) administrative-law appellate-jurisdiction due-process estoppel inter-partes-review patent-law patent-trial-and-appeal-board-ptab time-bar Whether the Federal Circuit has appellate jurisdiction to review a PTAB decision denying inter partes review
19-414 Medtronic, Inc. v. Mark A. Barry Federal Circuit 2019-09-27 Denied Amici (2) burden-of-proof experimental-use federal-circuit patent-law patent-law-35-usc-102-b reduction-to-practice statutory-bar supreme-court Whether a process invention is reduced to practice when all of its elements are successfully performed or must also be determined to work for a furthe…
19-400 Garmin USA, Inc., et al. v. Cellspin Soft, Inc. Federal Circuit 2019-09-25 Denied Amici (1)Relisted (2) 35-usc-101 civil-procedure claim-construction eligibility inventive-claims inventive-concept judicial-review legal-question motion-to-dismiss patent patent-eligibility patent-law pleadings question-of-law subject-matter-eligibility Whether patent eligibility is a question of law for the court that can be resolved on a motion to dismiss, notwithstanding allegations in a complaint …
19-324 Technology Properties Limited LLC, et al. v. Huawei Technologies Co., Ltd., et al. Federal Circuit 2019-09-10 Denied Response Waived civil-procedure due-process standing supreme-court-precedent the-patent-act federal-circuit patent patent-act patent-law prosecution-history-disclaimer separation-of-powers supreme-court-precedent Whether the United States Court of Appeals for the Federal Circuit's development and application of the doctrine of 'prosecution history disclaimer' i…
19-253 Straight Path IP Group, LLC v. Apple Inc., et al. Federal Circuit 2019-08-27 Denied Response RequestedResponse WaivedRelisted (2) appellate-review civil-procedure due-process federal-circuit fifth-amendment patent patent-infringement patent-law procedural-due-process summary-judgment Whether Rule 36(e) of the Federal Circuit's Rules of Procedure violates the Fifth Amendment by authorizing panels of the Federal Circuit to affirm, wi…
19-167 Galen J. Suppes v. Curators of the University of Missouri Missouri 2019-08-05 Denied Response Waived civil-procedure due-process equal-protection fourteenth-amendment invention-rights Jurisdiction Patent-Law patent-misuse standing takings university-ownership Was the Judgment's demand of perpetual (no limit in time or geography) and unconditional payment of remunerations of sixteen years of Defendant Suppes…
19-43 Power Analytics Corporation v. Operation Technology, Inc., et al. Federal Circuit 2019-07-05 Denied Response RequestedRelisted (2) 35-usc-101 alice-standard alice-v-cls-bank federal-circuit patent-eligibility patent-law patent-litigation rule-36-affirmance section-101 Has the Federal Circuit correctly implemented the standards for patent eligibility set forth in 35 U.S.C. § 101 and Alice v. CLS Bank?
18-1549 Zimmer, Inc., et al. v. Stryker Corporation, et al. Federal Circuit 2019-06-18 Denied enhanced-damages federal-circuit halo-v-pulse objective-recklessness patent-damages patent-law seagate-test subjective-intent willful-infringement willfulness Whether enhanced patent damages can be awarded without regard to whether there was an objectively high risk of infringement based on a finding of negl…
18A1325 Power Analytics Corporation v. Operation Technology, Inc., et al. Federal Circuit 2019-06-18 Presumed Complete alice-corp claim-construction federal-circuit patent-eligibility patent-law section-101 Whether the Federal Circuit has improperly interpreted patent eligibility standards under 35 U.S.C. § 101 in a manner inconsistent with Supreme Court …
18-1515 Eli Lilly and Company v. Erfindergemeinschaft UroPep GbR Federal Circuit 2019-06-06 Denied Amici (3)Response RequestedResponse WaivedRelisted (2) 35-usc-112 ariad-pharmaceuticals claim-construction enablement functional-claiming halliburton-oil-well-cementing halliburton-oil-well-cementing-co-v-walker halliburton-precedent patent-claims patent-eligibility patent-law point-of-novelty single-step-claim written-description Whether a single-step patent claim that describes its point of novelty solely in functional terms violates the rule against functional claiming
18A1266 Straight Path IP Group, LLC v. Apple Inc., et al. Federal Circuit 2019-06-05 Presumed Complete appellate-review certiorari federal-circuit jurisdictional-issue patent-law time-extension Whether the Federal Circuit's panel and en banc decisions in a patent-related dispute between Straight Path IP Group and technology companies raise si…
18-9383 Lakshmi Arunachalam v. United States District Court for the Northern District of California, et al. Ninth Circuit 2019-05-22 Denied Response WaivedRelisted (2)IFP 1st-amendment 42-usc-1983 civil-rights constitutional-rights due-process equal-protection erroneous-decisions first-amendment judicial-misconduct patent-law patent-rights Whether the lower court vacating hearings and arbitrarily ordering Petitioner to amend her complaint and the Judge acting as attorney to Defendants or…
18-1418 Senju Pharmaceutical Co., Ltd., et al. v. Akorn, Inc. Federal Circuit 2019-05-13 Denied 35-usc-144 federal-circuit mandate non-obviousness obviousness-standard opinion patent-appeal patent-appeals patent-law patent-trial-and-appeal-board rule-36 statutory-interpretation Whether 35 U.S.C. § 144's directive that the Federal Circuit shall issue ... its mandate and opinion' in all appeals from the Patent and Trademark Off…
18-1289 Allergan, Inc., et al. v. Teva Pharmaceuticals USA, Inc., et al. Federal Circuit 2019-04-10 Denied Response Waived blocking-patent blocking-patent-doctrine commercial-success graham-v-john-deere long-felt-need objective-indicia objective-indicia-of-non-obviousness obviousness patent-law patent-law-doctrine-of-obviousness prior-art Whether the Federal Circuit erred in holding that objective indicia of non-obviousness may be partially or entirely discounted where the development o…
18-1280 Acorda Therapeutics, Inc. v. Roxane Laboratories, Inc., et al. Federal Circuit 2019-04-08 Denied Amici (5) blocking-patent-doctrine blocking-patents burden-of-proof graham-v-john-deere nonobviousness objective-indicia obviousness patent patent-law patent-obviousness pharmaceutical-innovation prior-art Whether objective indicia of nonobviousness may be partially or entirely discounted where the development of the invention was allegedly 'blocked' by …
18-1274 In Re Urvashi Bhagat 2019-04-04 Denied Amici (2)Response Waived 35-usc-101 administrative-procedure administrative-procedure-act bilski-v-kappos federal-circuit-discretion graham-v-deere graham-v-john-deere judicial-discretion patent-eligibility patent-eligibility-35-usc-101 patent-law statutory-interpretation supreme-court-precedent uspto-discretion Whether the USPTO abused its discretion by refusing to allow claims that passed every requirement of Title 35 by insisting on extra-statutory requirem…
18-1144 Natural Alternatives International, Inc. v. Andrei Iancu, Director, United States Patent and Trademark Office Federal Circuit 2019-03-05 Denied Response Waived administrative-law agency-deference agency-guidance federal-circuit intellectual-property judicial-review patent-law patent-trial-and-appeal-board patent-trial-and-appeals-board priority property-law property-rights trips Did the Court of Appeals for the Federal Circuit err in analyzing rulings by the Patent Trial and Appeals Board
18-1072 James J. Macor v. United States Patent and Trademark Office Federal Circuit 2019-02-15 Denied Response Waived 35-usc-102 35-usc-103 administrative-law analogous-art obviousness obviousness-standard patent patent-examination patent-law prior-art statutory-interpretation Whether the standard for determining if prior art is 'analogous' in making rejections under 35 U.S.C. § 103(a) as obvious, and whether a finding of no…
18-999 Atlanta Gas Light Company v. Bennett Regulator Guards, Inc. Federal Circuit 2019-01-31 GVR Amici (1)Relisted (3) 35-usc-314 35-usc-315 administrative-procedure administrative-review america-invents-act dismissal-without-prejudice federal-circuit-jurisdiction inter-partes-review jurisdiction patent patent-law patent-review-procedure-35-usc-314-315 patent-trial-and-appeal-board standing time-bar Did the Federal Circuit err in concluding that it had jurisdiction to review the Board's decision to institute inter partes review
18-988 RPD Holdings, L.L.C. v. Tech Pharmacy Services, dba Advanced Pharmacy Services Fifth Circuit 2019-01-29 Denied Response Waived asset-assumption asset-valuation assumption-and-assignment assumption-assignment bankruptcy-code bankruptcy-sale bankruptcy-trustees collateral-attack executory-contract finality-of-bankruptcy-sales patent-law patent-license What happens to an undisclosed executory contract under the Bankruptcy Code?
18-7435 James Arthur Biggins v. Carl C. Danberg, et al. Third Circuit 2019-01-15 Denied IFP 35-usc-101 civil-procedure damages due-process jurisdiction patent patent-eligibility patent-infringement patent-law standing takings Whether the lower court erred in its interpretation and application of the relevant patent law statutes
18-916 Thryv, Inc., fka Dex Media, Inc. v. Click-To-Call Technologies, LP, et al. Federal Circuit 2019-01-15 Judgment Issued Amici (18)Relisted (3) 35-usc-314 35-usc-315 america-invents-act cuozzo inter-partes-review patent-infringement patent-law patent-trial-and-appeal-board ptab section-315b time-bar wi-fi-one Whether 35 U.S.C. § 314(d) permits appeal of the PTAB's decision to institute an inter partes review upon finding that § 315(b)'s time bar did not app…
18-899 Saint Regis Mohawk Tribe, et al. v. Mylan Pharmaceuticals, Inc., et al. Federal Circuit 2019-01-11 Denied administrative-law administrative-proceeding federal-circuit indian-tribe inter-partes-review patent-challenge patent-law patent-office patent-trial-and-appeal-board sovereign-immunity tribal-sovereign-immunity Whether inter partes review before the Patent Trial and Appeal Board is the type of proceeding in which tribal sovereign immunity may be asserted
18-823 ZUP, LLC v. Nash Manufacturing, Inc. Federal Circuit 2018-12-28 Denied Amici (1)Response Waived invention invention-evaluation legal-analysis long-felt-need non-obviousness obviousness obviousness-standard patent patent-invalidity patent-law prima-facie prior-art rebuttal secondary-considerations Whether evidence of 'secondary considerations' is less important in rebutting prima facie evidence of obviousness
18-801 Laura Peter, Deputy Director, Patent and Trademark Office v. NantKwest, Inc. Federal Circuit 2018-12-21 Judgment Issued Amici (11)Relisted (2) 35-usc-145 administrative-law civil-action civil-procedure due-process federal-circuit judicial-review patent patent-act patent-application patent-law personnel-expenses standing statutory-interpretation uspto USPTO-litigation Whether the phrase '[a]ll the expenses of the proceedings' in 35 U.S.C. 145 encompasses the personnel expenses the USPTO incurs when its employees, in…
18-779 Power Integrations Inc. v. Fairchild Semiconductor International, Inc., et al. Federal Circuit 2018-12-19 Denied apportionment customer-demand entire-market-value-rule federal-circuit patent-damages patent-infringement patent-law patent-litigation willful-infringement Whether a plaintiff that proves that a patented feature creates the basis for customer demand for infringing products is entitled to patent damages ba…
18-692 Mylan Pharmaceuticals Inc., et al. v. UCB, Inc., et al. Federal Circuit 2018-11-27 Denied Amici (3)Response Waived 35-usc-103 double-patenting federal-circuit graham-factors graham-v-john-deere invention-disclosure lead-compound-test obviousness patent-eligibility patent-law patent-law-doctrine-of-double-patenting patent-validity prior-art Whether a patentee may obtain a second patent on the same invention actually covered by a former patent to the same patentee
18-599 Wi-Fi One, LLC v. Broadcom Corporation, et al. Federal Circuit 2018-11-07 Denied Response Waived 35-usc-315b administrative-law administrative-procedure-act administrative-procedure-act-apa indemnity-agreements inter-partes-review inter-partes-review-ipr judicial-review patent-law patent-trial-and-appeal-board patent-trial-and-appeal-board-ptab standard-of-review time-bar Whether the PTAB panel violated the Administrative Procedure Act by refusing to admit known indemnity agreements into evidence when deciding whether t…
18-600 Texas Advanced Optoelectronic Solutions, Inc. v. Renesas Electronics America, Inc., fka Intersil Corporation Federal Circuit 2018-11-07 Denied CVSGAmici (3)Relisted (2) 35-usc-271 commercial-transactions extraterritoriality federal-circuit infringement international-relations offer-to-sell patent patent-infringement patent-law statutory-interpretation united-states-code venue Whether an 'offer to sell' under 35 U.S.C. § 271(a) occurs where the offer is made or where the proposed sale will take place
18-495 Morris & Associates, Inc. v. John Bean Technologies Corporation Federal Circuit 2018-10-17 Denied claim-construction due-process equitable-estoppel federal-circuit implied-license judicial-procedure patent patent-claims patent-infringement patent-law reexamination scotus-precedent waiver Whether the Federal Circuit erred and contradicted a century of this Court's licensing precedent in holding that implied license rights to a patent ar…
18-441 Accord Healthcare, Inc., et al. v. UCB, Inc., et al. Federal Circuit 2018-10-09 Denied Amici (1)Response Waived 35-usc-103 lead-compound obviousness patent patent-invalidation patent-law pharmaceutical pharmaceutical-compound prior-art Whether the Federal Circuit erred in holding that a patent claim to an obvious modification of a prior art compound was not invalid as obvious under 3…
18-388 Nigel Parker, et al. v. Andrei Iancu, Under Secretary of Commerce for Intellectual Property and Director, Patent and Trademark Office Federal Circuit 2018-09-26 Denied Response Waived 5-usc-706(2)(e) administrative-law administrative-procedure agency-action agency-overreach arbitrary-and-capricious patent patent-law patent-office patent-office-rejection publication publication-standard publication-under-35-usc-102(b) record-evidence substantial-evidence Whether the substantial' evidence required to support agency action under 5 U.S.C. § 706(2)(E) must be evidence of record?
18-303 Henryk Oleksy v. General Electric Company Federal Circuit 2018-09-12 Denied Response Waived appellate-procedure civil-procedure counterclaim-dismissal court-precedent due-process federal-circuit finality finality-of-judgment judgment-finality patent patent-law precedent supervisory-power Whether district court judgment was final despite lack of express dismissal of invalidity counterclaim
18-314 Capella Photonics, Inc. v. Cisco Systems, Inc., et al. Federal Circuit 2018-09-11 Denied Amici (1)Response Waived 35-usc-144 appellate-review due-process federal-circuit judicial-procedure judicial-review mandamus patent-appeals patent-law patent-trial-and-appeal-board statutory-interpretation Whether the Federal Circuit's practice of routinely issuing judgments without opinions in appeals from the Patent Trial and Appeal Board violates 35 U…
18-252 Real Estate Alliance Ltd. v. Move, Inc., et al. Federal Circuit 2018-08-28 Denied Relisted (2) 35-usc-101 alice-corp-v-cls-bank alice-test alice-v-cls-bank computer-user-interface fact-finding federal-circuit inventive-concept patent-claims patent-eligibility patent-infringement patent-law well-understood-routine-and-conventional Whether an ordered combination of elements in a patent claim is 'well-understood, routine and conventional' to a skilled artisan in the relevant field…
18-183 Advanced Audio Devices, LLC v. HTC Corporation, et al. Federal Circuit 2018-08-09 Denied Amici (2)Response Waived 5th-amendment aia america-invents-act constitutional-law due-process fifth-amendment inter-partes-review patent patent-law patents takings-clause Whether inter partes review (IPR) of patents filed before enactment of the Leahy-Smith America Invents Act ("AIA") violates the Takings Clause of the …
18-127 Amgen Inc., et al. v. Sanofi, et al. Federal Circuit 2018-07-27 Denied Amici (1)Response RequestedRelisted (2) 35-usc-112 biotechnology enablement federal-circuit innovation patent-law possession statutory-interpretation written-description Whether the standard for determining the adequacy of the 'written description of the invention' should be as the statute says—that the description mus…
18-109 Ariosa Diagnostics, Inc. v. Illumina, Inc. Federal Circuit 2018-07-24 Denied CVSGAmici (3)Response WaivedRelisted (2) 35-usc-102 35-usc-119 disclosure federal-circuit filing-date patent patent-application patent-law patent-prior-art prior-art priority subject-matter Unclaimed disclosures in a published patent application and an earlier application it relies on for priority enter the public domain and thus become p…
18-77 Advanced Video Technologies LLC v. HTC Corporation, et al. Federal Circuit 2018-07-17 Denied Amici (1) civil-procedure federal-circuit involuntary-plaintiff joinder patent patent-law rule-19 standing supreme-court Did the Federal Circuit properly create an exception to Rule 19 of the Federal Rules of Civil Procedure in patent law, requiring a dismissal of a case…
18-52 Paul Andrew Leitner-Wise v. LWRC International, LLC, et al. Federal Circuit 2018-07-10 Denied Response Waived 35-usc-100 35-usc-281 patent-assignment patent-fraud patent-infringement patent-law patent-royalties patent-standing patent-uniformity Whether the original inventor maintains statutory standing to sue for patent infringement under 35 U.S.C. § 281 even after assigning the patent, if th…